{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-012498","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.607916+00:00","generated_at":"2026-05-15T05:47:03.570585+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Pulse Biosciences posts investor deck with nsPFA cath lab study details and 2026 goals","bullets":["New details disclosed on pivotal clinical study of nsPFA Cardiac Catheter for atrial fibrillation.","Next-generation nPulse cardiac catheter under development described in the deck.","2026 corporate goals summarized across electrophysiology, cardiac surgery, and soft tissue ablation."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-012498","json":"https://secwatch.observer/filing/0001437749-26-012498.json","markdown":"https://secwatch.observer/filing/0001437749-26-012498.md","text":"https://secwatch.observer/filing/0001437749-26-012498.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926012498/0001437749-26-012498-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926012498/plse20260415_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:47:03.570585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}